trending Market Intelligence /marketintelligence/en/news-insights/trending/cUM9IcgNpJS2pQ8SWXtfYQ2 content esgSubNav
In This List

Editas Medicine CFO to step down

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Editas Medicine CFO to step down

Editas Medicine Inc. said Andrew Hack would resign as the company's CFO to pursue other business interests, effective March 1, 2019.

The company said it is looking for a replacement.

Cambridge, Mass.-based Editas Medicine operates as a genome editing company.